Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ("Zimmer Biomet"), a global medical technology leader, today announced it has completed the acquisition of Monogram Technologies Inc. ("Monogram"), an ...
Barchart on MSN
Zimmer Biomet Earnings Preview: What to Expect
With a market cap of $18.8 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company that designs, ...
Zimmer Biomet completes acquisition of Monogram Technologies to expand orthopedic robotics portfolio
Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $98.85 1.92% Open 98.935 Day High 101.083 52 Week High 133.6 52 Week ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. The equity portfolio returned 4.67% in ...
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes ...
Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options begin trading this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options become available today, for the June 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to ...
Zimmer Biomet (NYSE: ZBH) announced yesterday that it launched two new solutions for complex foot and ankle trauma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback